financetom
Business
financetom
/
Business
/
Equity Residential Q3 Normalized FFO, Revenue Rise; 2024 Outlook Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Equity Residential Q3 Normalized FFO, Revenue Rise; 2024 Outlook Updated
Oct 31, 2024 4:18 AM

05:07 PM EDT, 10/30/2024 (MT Newswires) -- Equity Residential ( EQR ) reported Q3 normalized funds from operations late Wednesday of $0.98 a share, up from $0.96 a year earlier.

Analysts surveyed by Capital IQ expected $0.98.

Revenue for the quarter ended Sept. 30 was $748.4 million, up from $724.1 million a year earlier. Analysts surveyed by Capital IQ expected $743.7 million.

The company expects normalized funds from operations of $0.98 to $1.02 a share. Analysts expect $1.01.

In 2024, the company expects normalized funds from operations of $3.87 to $3.91 a share versus prior guidance of $3.86 to $3.92. Analysts are looking for $3.89.

Price: 73.87, Change: -0.08, Percent Change: -0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amphenol to Acquire CommScope's Connectivity, Cable Solutions Business for $10.5 Billion
Amphenol to Acquire CommScope's Connectivity, Cable Solutions Business for $10.5 Billion
Aug 4, 2025
07:46 AM EDT, 08/04/2025 (MT Newswires) -- Amphenol ( APH ) said Monday it has agreed to acquire CommScope Holding's ( COMM ) connectivity and cable solutions, or CCS, business for $10.5 billion in cash. The deal will expand Amphenol's ( APH ) interconnect product offerings and is expected to be accretive to the company's EPS a year after closing....
BRIEF-XOMA Royalty to acquire LAVA Therapeutics for $1.16-$1.24 per share
BRIEF-XOMA Royalty to acquire LAVA Therapeutics for $1.16-$1.24 per share
Aug 4, 2025
Aug 4 (Reuters) - LAVA Therapeutics NV ( LVTX ): * XOMA ROYALTY ENTERS INTO AGREEMENT TO ACQUIRE LAVA THERAPEUTICS FOR BETWEEN $1.16 AND $1.24 PER SHARE IN CASH, PLUS A CONTINGENT VALUE RIGHT * XOMA ROYALTY CORP ( XOMA ) - ACQUISITION INCLUDES CVR FOR 75% OF NET PROCEEDS * XOMA ROYALTY CORP ( XOMA ) - TO COMMENCE...
Chemours, DuPont, Corteva to Pay $875 Million to Resolve New Jersey Contamination Claims
Chemours, DuPont, Corteva to Pay $875 Million to Resolve New Jersey Contamination Claims
Aug 4, 2025
07:45 AM EDT, 08/04/2025 (MT Newswires) -- Chemours ( CC ) , DuPont ( DD ) and Corteva ( CTVA ) said Monday they have agreed to pay $875 million to the state of New Jersey to resolve pending environmental contamination claims. The settlement payments will be made over a 25-year period starting within 30 days after the entry of...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved